Abstract
The only effective way to provide individuals with herd immunity against the novel coronavirus [SARS-CoV-2] is to administer an effective vaccine that will help check the current pandemic status. In India, the central drugs standard control organization (CDSCO) has granted the emergency-use authorization [EUA] to three vaccines namely, Covishield (live vaccine, Oxford AstraZeneca, United Kingdom being manufactured by the Serum Institute of India), Covaxin (inactivated vaccine, Bharat Biotech, India) and Sputnik V (live vaccine, Gamaleya, Russia). However, there is a rising need for the efficacy of the vaccines to be proven against the “SARS-CoV-2 viral variants.” Also, human plasma is polyclonal in nature with an inherent propensity to identify multiple epitopes of either an antigen or pathogen. With this context in mind, the researchers hypothesize that using COVID-19 convalescent plasma [CCP] harvested from the locally recovered individuals [i.e. potential CCP donors] may be particularly beneficial in combating not only the founder SARS-CoV-2 virus but also the geographically determined SARS-CoV-2 variants among the regionally affected COVID-19 patients.
Keywords: Blood donors; Blood safety; COVID-19 convalescent plasma; Donor registry; Pandemic; Vaccine impact; Viral variants.
【저자키워드】 pandemic, Blood donors, Blood safety, COVID-19 convalescent plasma, Donor registry, Vaccine impact, Viral variants., 【초록키워드】 COVID-19, convalescent plasma, Efficacy, Vaccine, Immunity, India, Russia, SARS-CoV-2 variant, SARS-CoV-2 virus, drug, variants, Novel coronavirus, Antigen, Epitopes, Blood donors, Viral, pathogen, SARS-CoV-2 variants, Inactivated vaccine, herd immunity, Viral variants, convalescent, United Kingdom, AstraZeneca, COVID-19 patients, COVID-19 convalescent plasma, Human plasma, CCP, Bharat, the vaccines, live vaccine, Oxford, individual, help, pandemic status, mind, researcher, multiple epitopes, effective, polyclonal, combating, identify, affected, the vaccine, inherent, rising, administer, multiple epitope, 【제목키워드】 convalescent plasma, variant, help, SARS-CoV-2 viral,